COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities

被引：16

作者：

Manansala, Michael ^{[1
]}

Chopra, Amit ^{[2
]}

Baughman, Robert P. ^{[3
]}

Novak, Richard ^{[4
]}

Lower, Elyse E. ^{[3
]}

Culver, Daniel A. ^{[5
]}

Korsten, Peter ^{[6
]}

Drake, Wonder P. ^{[7
]}

Judson, Marc A. ^{[2
]}

Sweiss, Nadera ^{[8
]}

机构：

[1] Univ Illinois, Dept Med, Acad Internal Med, Chicago, IL USA

[2] Albany Med Coll, Div Pulm & Crit Care Med, Dept Med, Albany, NY 12208 USA

[3] Univ Cincinnati, Med Ctr, Dept Med, Cincinnati, OH 45267 USA

[4] Univ Illinois, Dept Med, Div Infect Dis, Chicago, IL USA

[5] Cleveland Clin, Dept Pulm Med, Cleveland, OH 44106 USA

[6] Univ Med Ctr Gottingen, Dept Nephrol & Rheumatol, Gottingen, Germany

[7] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA

[8] Univ Illinois, Dept Med, Div Rheumatol, Chicago, IL 60607 USA

来源：

FRONTIERS IN MEDICINE | 2021年 / 8卷

关键词：

coronavirus; -COVID-19; sarcoidosis; vaccination; immunosuppression; SARS-CoV-2; INFLUENZA VACCINATION; RHEUMATOID-ARTHRITIS; IMMUNOGENICITY; STATES;

D O I：

10.3389/fmed.2021.672028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sarcoidosis is an immune mediated chronic inflammatory disorder that is best characterized by non-caseating granulomas found in one or more affected organs. The COVID-19 pandemic poses a challenge for clinicians caring for sarcoidosis patients who may be at increased risk of infection compared to the general population. With the recent availability of COVID-19 vaccines, it is expected that clinicians raise questions regarding efficacy and safety in sarcoidosis. However, studies examining safety and efficacy of vaccines in sarcoidosis are lacking. In this review, we examine the current literature regarding vaccination in immunocompromised populations and apply them to sarcoidosis patients. The available literature suggests that vaccines are safe and effective in patients with autoimmune disorders and in those taking immunosuppressive medications. We strongly recommend the administration of COVID-19 vaccines in patients with sarcoidosis. We also present a clinical decision algorithm to provide guidance on vaccination of sarcoidosis patients against COVID-19.

引用

页数：7

共 41 条

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[2] Sarcoidosis: a review for the internist [J].

Bargagli, Elena ;

Prasse, Antje .

INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (03) :325-331

[3] RISK AND OUTCOME OF COVID-19 INFECTION IN SARCOIDOSIS PATIENTS: RESULTS OF A SELF-REPORTING QUESTIONNAIRE [J].

Baughman, Robert P. ;

Lower, Elyse E. ;

Buchanan, Mindy ;

Rottoli, Paola ;

Drent, Marjolein ;

Sellares, Jacobo ;

Terwiel, Michelle ;

Elfferich, Marjon ;

Francesqui, Joel ;

Barriuso Cabrerizo, Maria Rita ;

Sweiss, Nadera ;

Martone, Filippo ;

Al-Hakim, Tamara ;

Judson, Marc A. .

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2020, 37 (04)

[4] Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic [J].

Burger, Andrew E. ;

Reither, Eric N. ;

Mamelund, Svenn-Erik ;

Lim, Sojung .

VACCINE, 2021, 39 (06) :943-951

[5] Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis [J].

Calender, Alain ;

Israel-Biet, Dominique ;

Valeyre, Dominique ;

Pacheco, Yves .

TRENDS IN IMMUNOLOGY, 2020, 41 (10) :856-+

[6] Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis [J].

Calender, Alain ;

Lim, Clarice X. ;

Weichhart, Thomas ;

Buisson, Adrien ;

Besnard, Valerie ;

Rollat-Farnier, Pierre Antoine ;

Bardel, Claire ;

Roy, Pascal ;

Cottin, Vincent ;

Devouassoux, Gilles ;

Finat, Amelie ;

Pinson, Stephane ;

Lebecque, Serge ;

Nunes, Hilario ;

Israel-Biet, Dominique ;

Bentaher, Abderazzaq ;

Valeyre, Dominique ;

Pacheco, Yves .

EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (02)

[7] Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2 [J].

Curtius, J. ;

Granzin, M. ;

Schrod, J. .

AEROSOL SCIENCE AND TECHNOLOGY, 2021, 55 (05) :586-599

[8] Severe infections in sarcoidosis Incidence, predictors and long-term outcome in a cohort of 585 patients [J].

Dureault, Amelie ;

Chapelon, Catherine ;

Biard, Lucie ;

Domont, Fanny ;

Savey, Lea ;

Bodaghi, Bahram ;

Pourcher, Valerie ;

Rigon, Matthieu Resche ;

Cacoub, Patrice ;

Saadoun, David .

MEDICINE, 2017, 96 (49)

[9] Refractory Sarcoidosis: A Review [J].

El Jammal, Thomas ;

Jamilloux, Yvan ;

Gerfaud-Valentin, Mathieu ;

Valeyre, Dominique ;

Seve, Pascal .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 :323-345

[10] Human Coronavirus: Host-Pathogen Interaction [J].

Fung, To Sing ;

Liu, Ding Xiang .

ANNUAL REVIEW OF MICROBIOLOGY, VOL 73, 2019, 73 :529-557

← 1 2 3 4 5 →